248 related articles for article (PubMed ID: 20477935)
1. Cellular localization of the organic cation transporters, OCT1 and OCT2, in brain microvessel endothelial cells and its implication for MPTP transport across the blood-brain barrier and MPTP-induced dopaminergic toxicity in rodents.
Lin CJ; Tai Y; Huang MT; Tsai YF; Hsu HJ; Tzen KY; Liou HH
J Neurochem; 2010 Aug; 114(3):717-27. PubMed ID: 20477935
[TBL] [Abstract][Full Text] [Related]
2. Interaction between nicotine and MPTP/MPP+ in rat brain endothelial cells.
Liou HH; Hsu HJ; Tsai YF; Shih CY; Chang YC; Lin CJ
Life Sci; 2007 Aug; 81(8):664-72. PubMed ID: 17689566
[TBL] [Abstract][Full Text] [Related]
3. Decreased expression of organic cation transporters, Oct1 and Oct2, in brain microvessels and its implication to MPTP-induced dopaminergic toxicity in aged mice.
Wu KC; Lu YH; Peng YH; Tsai TF; Kao YH; Yang HT; Lin CJ
J Cereb Blood Flow Metab; 2015 Jan; 35(1):37-47. PubMed ID: 25248837
[TBL] [Abstract][Full Text] [Related]
4. Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.
Urakami Y; Okuda M; Masuda S; Saito H; Inui KI
J Pharmacol Exp Ther; 1998 Nov; 287(2):800-5. PubMed ID: 9808712
[TBL] [Abstract][Full Text] [Related]
5. Saturable distribution of tacrine into the striatal extracellular fluid of the rat: evidence of involvement of multiple organic cation transporters in the transport.
Sung JH; Yu KH; Park JS; Tsuruo T; Kim DD; Shim CK; Chung SJ
Drug Metab Dispos; 2005 Mar; 33(3):440-8. PubMed ID: 15547049
[TBL] [Abstract][Full Text] [Related]
6. D-deprenyl protects nigrostriatal neurons against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic neurotoxicity.
Muralikrishnan D; Samantaray S; Mohanakumar KP
Synapse; 2003 Oct; 50(1):7-13. PubMed ID: 12872288
[TBL] [Abstract][Full Text] [Related]
7. Cell membrane transport of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the liver and systemic bioavailability.
Yang MC; McLean AJ; Le Couteur DG
Biochem Biophys Res Commun; 2001 Nov; 289(1):130-6. PubMed ID: 11708789
[TBL] [Abstract][Full Text] [Related]
8. Effects of lipopolysaccharide on the expression of plasma membrane monoamine transporter (PMAT) at the blood-brain barrier and its implications to the transport of neurotoxins.
Wu KC; Lu YH; Peng YH; Hsu LC; Lin CJ
J Neurochem; 2015 Dec; 135(6):1178-88. PubMed ID: 26376205
[TBL] [Abstract][Full Text] [Related]
9. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.
Calon F; Lavertu N; Lemieux AM; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T
Synapse; 2001 Jun; 40(3):225-34. PubMed ID: 11304760
[TBL] [Abstract][Full Text] [Related]
10. [A comparative study of hemantane and amantadine effects on dopamine transporter expression in brain of normal and MPTP-treated C57BL/6 mice].
Zimin IA; Logvinov IO; Antipova TA; Kovalev GI
Eksp Klin Farmakol; 2011; 74(1):11-4. PubMed ID: 21476268
[TBL] [Abstract][Full Text] [Related]
11. Mesenchymal stem cell transplantation attenuates blood brain barrier damage and neuroinflammation and protects dopaminergic neurons against MPTP toxicity in the substantia nigra in a model of Parkinson's disease.
Chao YX; He BP; Tay SS
J Neuroimmunol; 2009 Nov; 216(1-2):39-50. PubMed ID: 19819031
[TBL] [Abstract][Full Text] [Related]
12. Studies on species sensitivity to the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Part 1: Systemic administration.
Giovanni A; Sieber BA; Heikkila RE; Sonsalla PK
J Pharmacol Exp Ther; 1994 Sep; 270(3):1000-7. PubMed ID: 7932147
[TBL] [Abstract][Full Text] [Related]
13. Localization of organic cation/carnitine transporter (OCTN2) in cells forming the blood-brain barrier.
Miecz D; Januszewicz E; Czeredys M; Hinton BT; Berezowski V; Cecchelli R; Nałecz KA
J Neurochem; 2008 Jan; 104(1):113-23. PubMed ID: 17995936
[TBL] [Abstract][Full Text] [Related]
14. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.
Lee WK; Reichold M; Edemir B; Ciarimboli G; Warth R; Koepsell H; Thévenod F
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1504-13. PubMed ID: 19357179
[TBL] [Abstract][Full Text] [Related]
15. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity.
Zuddas A; Fascetti F; Corsini GU; Piccardi MP
Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437
[TBL] [Abstract][Full Text] [Related]
16. A novel thiol antioxidant that crosses the blood brain barrier protects dopaminergic neurons in experimental models of Parkinson's disease.
Bahat-Stroomza M; Gilgun-Sherki Y; Offen D; Panet H; Saada A; Krool-Galron N; Barzilai A; Atlas D; Melamed E
Eur J Neurosci; 2005 Feb; 21(3):637-46. PubMed ID: 15733082
[TBL] [Abstract][Full Text] [Related]
17. MPTP treatment in mice does not transmit and cause Parkinsonian neurotoxicity in non-treated cagemates through close contact.
Lau YS; Novikova L; Roels C
Neurosci Res; 2005 Aug; 52(4):371-8. PubMed ID: 15936837
[TBL] [Abstract][Full Text] [Related]
18. On the mechanisms underlying 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. II. Susceptibility among mammalian species correlates with the toxin's metabolic patterns in brain microvessels and liver.
Riachi NJ; Harik SI; Kalaria RN; Sayre LM
J Pharmacol Exp Ther; 1988 Feb; 244(2):443-8. PubMed ID: 3258032
[TBL] [Abstract][Full Text] [Related]
19. Regional biotransformation of MPTP in the CNS of rodents and its relation to neurotoxicity.
Nwanze E; Souverbie F; Jonsson G; Sundström E
Neurotoxicology; 1995; 16(3):469-77. PubMed ID: 8584278
[TBL] [Abstract][Full Text] [Related]
20. The organic cation transporters (OCT1, OCT2, EMT) and the plasma membrane monoamine transporter (PMAT) show differential distribution and cyclic expression pattern in human endometrium and early pregnancy decidua.
Bottalico B; Noskova V; Pilka R; Larsson I; Domanski H; Casslén B; Hansson SR
Mol Reprod Dev; 2007 Oct; 74(10):1303-11. PubMed ID: 17393420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
